STATKING's biostatisticians have the education and industry experience necessary to plan and execute a data analysis strategy for your studies. Our biostatisticians have a proven record of interacting with FDA review committees to produce agreements necessary to move your projects forward. Count on STATKING biostatisticians to provide the following services:

• Protocol Development/Experimental Design Consulting
• Sample Size/Power Calculations
• Strategic Planning for Clinical Research Plans
• Consulting on Statistically Related Regulatory Issues
• Efficacy and Safety Data Analyses
• Data Analyses/Meta Analyses for INDs, IDEs, NDAs, 510Ks, PMAs and ANDAs
• Service on Data Monitoring Committees and Data Safety Monitoring Boards
• Interim Analyses/Interim Analysis Plans
• Statistical Analysis Plans
• Stand Alone Statistical Reports
• Integrated Clinical Study Reports